Cargando…

Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey

Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickel, Steffen, Grimm, Clemens, Popp, Maria, Struwe, Claudia, Sachkova, Alexandra, Golinski, Martin, Seeber, Christian, Fichtner, Falk, Heise, Daniel, Kranke, Peter, Meissner, Winfried, Laudi, Sven, Voigt-Radloff, Sebastian, Meerpohl, Joerg J., Jabs, Jonas, Mutters, Nico T., Moerer, Onnen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204667/
https://www.ncbi.nlm.nih.gov/pubmed/34194922
http://dx.doi.org/10.3205/dgkh000392
_version_ 1783708379212939264
author Dickel, Steffen
Grimm, Clemens
Popp, Maria
Struwe, Claudia
Sachkova, Alexandra
Golinski, Martin
Seeber, Christian
Fichtner, Falk
Heise, Daniel
Kranke, Peter
Meissner, Winfried
Laudi, Sven
Voigt-Radloff, Sebastian
Meerpohl, Joerg J.
Jabs, Jonas
Mutters, Nico T.
Moerer, Onnen
author_facet Dickel, Steffen
Grimm, Clemens
Popp, Maria
Struwe, Claudia
Sachkova, Alexandra
Golinski, Martin
Seeber, Christian
Fichtner, Falk
Heise, Daniel
Kranke, Peter
Meissner, Winfried
Laudi, Sven
Voigt-Radloff, Sebastian
Meerpohl, Joerg J.
Jabs, Jonas
Mutters, Nico T.
Moerer, Onnen
author_sort Dickel, Steffen
collection PubMed
description Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 patients was conducted in December 2020. Results: We received responses from 205 German ICUs that had treated COVID-19 patients to date. There was wide variation in the use of PPE. Polymerase Chain reaction (PCR) testing for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) was used by 94.8% of the units, with an average waiting time of 12 hours for the result. 18.7% of the respondents prescribed antibiotic prophylaxis in COVID-19 patients. Conclusion: We found a high variance in essential care strategies for COVID-19 patients on German intensive care units. This included differences in infection prophylaxis, personal protective equipment, and the indication of prophylactic antibiotic therapy. Based on our results, we recommend further studies to quantify and improve guideline adherence.
format Online
Article
Text
id pubmed-8204667
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-82046672021-06-29 Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey Dickel, Steffen Grimm, Clemens Popp, Maria Struwe, Claudia Sachkova, Alexandra Golinski, Martin Seeber, Christian Fichtner, Falk Heise, Daniel Kranke, Peter Meissner, Winfried Laudi, Sven Voigt-Radloff, Sebastian Meerpohl, Joerg J. Jabs, Jonas Mutters, Nico T. Moerer, Onnen GMS Hyg Infect Control Article Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 patients was conducted in December 2020. Results: We received responses from 205 German ICUs that had treated COVID-19 patients to date. There was wide variation in the use of PPE. Polymerase Chain reaction (PCR) testing for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) was used by 94.8% of the units, with an average waiting time of 12 hours for the result. 18.7% of the respondents prescribed antibiotic prophylaxis in COVID-19 patients. Conclusion: We found a high variance in essential care strategies for COVID-19 patients on German intensive care units. This included differences in infection prophylaxis, personal protective equipment, and the indication of prophylactic antibiotic therapy. Based on our results, we recommend further studies to quantify and improve guideline adherence. German Medical Science GMS Publishing House 2021-06-14 /pmc/articles/PMC8204667/ /pubmed/34194922 http://dx.doi.org/10.3205/dgkh000392 Text en Copyright © 2021 Dickel et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Dickel, Steffen
Grimm, Clemens
Popp, Maria
Struwe, Claudia
Sachkova, Alexandra
Golinski, Martin
Seeber, Christian
Fichtner, Falk
Heise, Daniel
Kranke, Peter
Meissner, Winfried
Laudi, Sven
Voigt-Radloff, Sebastian
Meerpohl, Joerg J.
Jabs, Jonas
Mutters, Nico T.
Moerer, Onnen
Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title_full Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title_fullStr Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title_full_unstemmed Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title_short Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey
title_sort infection control, prophylactic antibiotics, and testing for sars-cov-2 and ppe on german intensive care units: results from a national mixed methods survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204667/
https://www.ncbi.nlm.nih.gov/pubmed/34194922
http://dx.doi.org/10.3205/dgkh000392
work_keys_str_mv AT dickelsteffen infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT grimmclemens infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT poppmaria infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT struweclaudia infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT sachkovaalexandra infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT golinskimartin infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT seeberchristian infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT fichtnerfalk infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT heisedaniel infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT krankepeter infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT meissnerwinfried infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT laudisven infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT voigtradloffsebastian infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT meerpohljoergj infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT jabsjonas infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT muttersnicot infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT moereronnen infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey
AT infectioncontrolprophylacticantibioticsandtestingforsarscov2andppeongermanintensivecareunitsresultsfromanationalmixedmethodssurvey